Harekrishna Roy

592 total citations
42 papers, 382 citations indexed

About

Harekrishna Roy is a scholar working on Pharmaceutical Science, Molecular Biology and Biomaterials. According to data from OpenAlex, Harekrishna Roy has authored 42 papers receiving a total of 382 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Pharmaceutical Science, 8 papers in Molecular Biology and 6 papers in Biomaterials. Recurrent topics in Harekrishna Roy's work include Advanced Drug Delivery Systems (14 papers), Drug Solubulity and Delivery Systems (12 papers) and Advancements in Transdermal Drug Delivery (7 papers). Harekrishna Roy is often cited by papers focused on Advanced Drug Delivery Systems (14 papers), Drug Solubulity and Delivery Systems (12 papers) and Advancements in Transdermal Drug Delivery (7 papers). Harekrishna Roy collaborates with scholars based in India, Slovakia and Italy. Harekrishna Roy's co-authors include Sisir Nandi, Balaji Maddiboyina, M. Kavisri, Gandhi Sivaraman, Meivelu Moovendhan‬‬‬‬‬‬‬‬, Raghvendra A. Bohara, Jitendra Patel, G. Shiva Kumar, N. Krishna Jyothi and Stefano Leporatti and has published in prestigious journals such as SHILAP Revista de lepidopterología, RSC Advances and Current Pharmaceutical Design.

In The Last Decade

Harekrishna Roy

39 papers receiving 361 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Harekrishna Roy India 13 143 74 67 52 37 42 382
Maryam Shabbir Pakistan 13 137 1.0× 125 1.7× 51 0.8× 48 0.9× 40 1.1× 33 444
Flávia Almada do Carmo Brazil 15 159 1.1× 86 1.2× 76 1.1× 64 1.2× 51 1.4× 44 478
Dibyalochan Mohanty India 10 128 0.9× 57 0.8× 43 0.6× 21 0.4× 30 0.8× 30 318
Gladys E. Granero Argentina 10 120 0.8× 66 0.9× 46 0.7× 34 0.7× 40 1.1× 25 402
Salma M. Abdel-Hafez Egypt 7 194 1.4× 77 1.0× 101 1.5× 53 1.0× 23 0.6× 10 381
Simone Pinto Carneiro Germany 9 175 1.2× 144 1.9× 80 1.2× 82 1.6× 53 1.4× 27 494
Srinivas Ajjarapu United States 11 127 0.9× 138 1.9× 51 0.8× 47 0.9× 51 1.4× 13 364
Mohammad F. Bayan Jordan 13 81 0.6× 53 0.7× 57 0.9× 48 0.9× 57 1.5× 23 328
Anup Naha India 10 133 0.9× 43 0.6× 52 0.8× 37 0.7× 34 0.9× 37 323

Countries citing papers authored by Harekrishna Roy

Since Specialization
Citations

This map shows the geographic impact of Harekrishna Roy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harekrishna Roy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harekrishna Roy more than expected).

Fields of papers citing papers by Harekrishna Roy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Harekrishna Roy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harekrishna Roy. The network helps show where Harekrishna Roy may publish in the future.

Co-authorship network of co-authors of Harekrishna Roy

This figure shows the co-authorship network connecting the top 25 collaborators of Harekrishna Roy. A scholar is included among the top collaborators of Harekrishna Roy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Harekrishna Roy. Harekrishna Roy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Roy, Harekrishna, et al.. (2025). Novel delivery strategy: finasteride-loaded solid lipid nanoparticles for improved androgenetic alopecia therapy. RSC Advances. 15(23). 18715–18731. 2 indexed citations
3.
Roy, Harekrishna, et al.. (2025). Enhanced rivastigmine delivery through nanoemulsion and pyridoxine supplementation: An in-vivo study on Alzheimer's disease intervention. Nanomedicine Nanotechnology Biology and Medicine. 65. 102810–102810. 1 indexed citations
4.
Chettupalli, Ananda Kumar, et al.. (2024). Development and optimization of dapagliflozin oral nano-bilosomes using response surface method: in vitro evaluation, in vivo evaluation. Nanotheranostics. 9(1). 1–19. 1 indexed citations
5.
Patel, Jitendra, G. Shiva Kumar, Harekrishna Roy, et al.. (2024). From nature to nanomedicine: bioengineered metallic nanoparticles bridge the gap for medical applications. SHILAP Revista de lepidopterología. 19(1). 85–85. 31 indexed citations
6.
Roy, Harekrishna, et al.. (2023). N-trimethyl chitosan and tripalmitin loaded solid lipid nanoparticles of tofacitinib citrate: Characterization and in-vivo anti-inflammatory assessment. Journal of Drug Delivery Science and Technology. 87. 104789–104789. 15 indexed citations
7.
Maddiboyina, Balaji, et al.. (2023). Formulation, Characterization, and Taguchi Design Study of Eplerenone Lipid-Based Solid Dispersions Integrated with Gelucire. BioNanoScience. 13(2). 576–587. 11 indexed citations
8.
Maddiboyina, Balaji, et al.. (2023). Methicillin-resistant Staphylococcus aureus: novel treatment approach breakthroughs. SHILAP Revista de lepidopterología. 47(1). 16 indexed citations
9.
Roy, Harekrishna, et al.. (2023). Citicoline loaded nanoemulsion enriched with D-alpha-Tocopherol acetate and protein: Formulation and in-silico study. Journal of Drug Delivery Science and Technology. 82. 104340–104340. 15 indexed citations
11.
Maddiboyina, Balaji, et al.. (2023). Duloxetine hydrochloride enteric-coated pellets in capsules with delayed release: formulation and evaluation. Smart Science. 11(3). 434–446. 3 indexed citations
12.
Basu, D., et al.. (2023). To Investigate Growth Factor Receptor Targets and Generate CancerTargeting Inhibitors. Current Topics in Medicinal Chemistry. 23(30). 2877–2972. 4 indexed citations
13.
Maddiboyina, Balaji, et al.. (2023). Food and drug industry applications of microalgae Spirulina platensis: A review. Journal of Basic Microbiology. 63(6). 573–583. 45 indexed citations
15.
Roy, Harekrishna, et al.. (2022). Chitosan based urapidil microparticle development in approach to improve mechanical strength by cold hyperosmotic dextrose solution technique. Journal of Drug Delivery Science and Technology. 76. 103745–103745. 9 indexed citations
16.
Roy, Harekrishna & Sisir Nandi. (2019). In-Silico Modeling in Drug Metabolism and Interaction: Current Strategies of Lead Discovery. Current Pharmaceutical Design. 25(31). 3292–3305. 14 indexed citations
17.
Roy, Harekrishna, et al.. (2013). Formulation and design of sustained release matrix tablets of metformin hydrochloride: Influence of hypromellose and polyacrylate polymers. International Journal of Applied and Basic Medical Research. 3(1). 55–55. 34 indexed citations
18.
Roy, Harekrishna, et al.. (2012). Design of fast dissolving amlodipine besylate tablet formulations. Asian Journal of Pharmaceutics. 6(1). 51–59. 4 indexed citations
19.
Roy, Harekrishna, et al.. (2010). In-vitro antioxidant activity of hydro-alcoholic extract of leaves of Hybanthus enneaspermus (Linn.).. Journal of Pharmacy Research. 3(11). 2623–2624. 1 indexed citations
20.
Chakraborty, Avishek, et al.. (2010). Comparative study of antioxidant activity between ethanolic and aqueous extract of Cleome rutidosperma.. International Journal of Pharmaceutical Sciences and Research. 1(11). 112–116. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026